Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

EU Medicrime Convention

Wednesday the 16th November 2011

The Council of Europe has taken a major step to in its effort to fight the growing problem of counterfeit medicines by adopting a convention that includes, for the first time, criminal penalties for counterfeiting medicines, marketing medicines without authorization, being non-compliant with conformity requirements or falsifying related documents.

The scope of the “Medicrime Convention,” published in late October, includes drugs and medical devices for human or veterinary use as well as the active substances, raw materials, excipients and components used in their manufacture.

The convention directs its signatories to “take the necessary legislative and other measures to ensure that the offences established in accordance with this Convention are punishable by effective, proportionate and dissuasive sanctions, including criminal or non-criminal monetary sanctions, taking account of their seriousness.” Penalties will be applicable to both individuals and corporations.

The Convention will be open to member and non-member States of the Council of Europe and available for signature later this year.

Best regards,

Pete
Peter Gough, Partner
NSF-DBA Ltd.

Quick links

NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Boston and Ann Arbor, USA

A word from NSF Health Sciences

The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

Peter Gough

© NSF Health Sciences 2014

Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: pharmamail@nsf.org
US Office: NSF Health Sciences, 6th floor, 129 South St, Boston, MA 02111 | Tel: 1-857-277-0060 | Fax: 1-857-284-7207 | Email: USpharma@nsf.org